StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) bonds

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $406.23MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Vireo Growth reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2022

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Vireo Growth's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Chicago Atlantic term loans–$33.00M–
Commercial Loan9.25%$15.00M$0
First Lien Term Loan–$120.00M–
New Convertible Notes
Convertible at $19 a share
Floating + 5.00%$10.00M–
Promissory Note–$1.11M–
Promissory Note And Line Of Credit––$306.30M
Secured Debt10.50%$11.50M–
Term Loan12.00%$1.20M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Credit Facility$46.00M
Tenth Amendment Notes$10.00M

See a number that looks wrong?